Draft National Health Research Policy 2026: A Progressive Vision That Needs Sharper Implementation - Dr Raju Vaishya

The Draft National Health Research Policy 2026 is an important and timely attempt to redefine India’s health research landscape. It reflects a clear understanding that health research is no longer confined to laboratories and journals, but is central to health system strengthening, innovation, and national development. The policy is especially commendable for its broad scope, which includes clinical research, public health, implementation science, digital health, genomics, artificial intelligence, One Health, and translational medicine.

At the same time, the draft is better as a vision document than as an operational roadmap. Its aspirations are impressive, but the policy will ultimately be judged by how effectively it can be implemented across institutions, regions, and disciplines.

Strengths of the Draft

One of the most striking strengths of the draft is its multidisciplinary outlook. By moving beyond a narrow biomedical framework, it acknowledges the complexity of modern health challenges and the need for integrated solutions. The inclusion of One Health is particularly relevant in an era of zoonotic disease threats, antimicrobial resistance, and environmental change.

The policy also rightly emphasises translational research, which is essential for ensuring that scientific discoveries lead to real improvements in patient care and public health. Its focus on stronger linkages between academia, healthcare institutions, industry, and government agencies is a positive step toward reducing the long-standing gap between research generation and research use.

Another strength lies in its recognition of capacity building. The policy appropriately highlights the need for modern infrastructure, ethical oversight, institutional research offices, digital platforms, and training pathways for future researchers. This is especially important in India, where research capacity remains uneven across institutions and regions.

Gaps and Concerns

Despite its strengths, the draft has some weaknesses. The most important concern is the lack of specificity. The policy speaks convincingly about strengthening research ecosystems, but it provides limited detail on funding commitments, implementation timelines, measurable targets, and accountability structures. Without these, the policy may remain aspirational rather than actionable.

A second concern is the insufficient attention to the realities of clinical practice. Most clinician-researchers in India work under heavy service burdens, and the draft does not adequately address protected research time, dedicated staffing support, or incentives for academic productivity. If clinicians are expected to lead research, they need institutional and financial support.

The policy also needs a more robust framework for research evaluation. Publication numbers alone are no longer enough. A modern policy should assess translation into practice, policy influence, patents, technology transfer, multicentric collaborations, and patient outcomes.

Digital Health and AI

The draft is forward-looking in its treatment of digital health, artificial intelligence, and genomics. These areas offer enormous opportunities for improving diagnosis, treatment, surveillance, and health system efficiency. India’s digital health ecosystem could become a major asset for large-scale research if data systems are interoperable, secure, and ethically governed.

However, the policy must go further in addressing risks. Responsible AI requires validation, transparency, bias reduction, privacy protection, and regulatory oversight. Similarly, large health datasets must be governed with clear standards for data sharing, consent, and cybersecurity. Innovation without governance may create new inequities and ethical problems.

Research Governance

The policy deserves credit for stressing governance, ethics, and institutional accountability. Strong ethics committees, research management systems, and regulatory coordination are essential for credible and efficient research. These reforms can reduce delays and improve public trust.

Still, governance should not be reduced to compliance alone. A strong research culture also depends on integrity, reproducibility, responsible authorship, conflict-of-interest management, and open scientific practices. If the final policy incorporates these elements more explicitly, it will be much stronger.

Conclusion

The Draft National Health Research Policy 2026 is a thoughtful and ambitious document with the potential to transform India’s research ecosystem. It is modern in outlook, broad in scope, and aligned with national priorities. Its greatest strength is its recognition that health research is a strategic national investment. However, the main limitation could be a gap between vision and execution. The policy needs sharper funding commitments, clearer performance indicators, stronger support for clinician-scientists, and a more detailed framework for monitoring outcomes. If these issues are addressed in the final version, the policy could become a genuinely transformative roadmap for Indian health research.

Reference:

Department of Health Research, Ministry of Health and Family Welfare, Government of India. Draft National Health Research Policy 2026. New Delhi: Government of India; 2026. 

Disclaimer: The views expressed in this article are of the author and not of Medical Dialogues. The Editorial/Content team of Medical Dialogues has not contributed to the writing/editing/packaging of this article.